US Corporate Distress Financial Stress SEC Filings — January 29, 2026

30-01-2026

SunPower Inc. filed a Form 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities, with Item 9.01 for financial statements and exhibits. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, terms, or financial impacts provided. No positive or negative metrics, period-over-period changes, or strategic context were disclosed.

30-01-2026

Brand Engagement Network Inc. filed a multi-item 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02, with additional other events under Item 8.01. While the material agreement may signal strategic funding or partnership opportunities, the new financial obligation introduces potential debt risks and the equity sales raise shareholder dilution concerns. No quantitative details such as transaction values, share counts, or financial impacts were disclosed.

30-01-2026

GRI Bio, Inc. filed an 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details, financial metrics, transaction values, positive or negative changes, or other quantitative data are disclosed.

30-01-2026

ESS Tech, Inc. filed an 8-K on 2026-01-30 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, financial impacts, or other metrics are disclosed. AccNo: 0001628280-26-004263; File Size: 1 MB.

• ·Sector: not specified
• ·Source: us_sec
• ·File Size: 1 MB
• ·Multi-item filing: Yes (Items 1.01 and 9.01)
• ·Mandatory disclosure under SEC 8-K rules for Item 1.01

30-01-2026

The company filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-029721), reporting under Item 1.01 entry into a new Material Definitive Agreement and under Item 1.02 termination of a prior Material Definitive Agreement. Item 9.01 indicates Financial Statements and Exhibits were included. No specific details, dollar values, parties, strategic impacts, or financial metrics are disclosed.

30-01-2026

Bluejay Diagnostics, Inc. filed a Form 8-K on January 30, 2026, disclosing events under multiple items including Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing appears related to governance changes and shareholder vote outcomes, but no specific details on the nature of modifications, vote results, or financial impacts are provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

30-01-2026

Fat Brands, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004289), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing from the US market. No additional financial metrics, reasons for delisting, dollar values, or impacts were disclosed. This event signals a material regulatory compliance failure with no offsetting positive developments mentioned.

30-01-2026

Twin Hospitality Group Inc. filed a Form 8-K on 2026-01-30 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed. Sector is not specified.

• ·Accession Number: 0001493152-26-004291
• ·Filing size: 212 KB

30-01-2026

RICHTECH ROBOTICS INC. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. Item 8.01 reports other events, accompanied by financial statements and exhibits under Item 9.01. No specific transaction values, share counts, financial impacts, or detailed terms are disclosed.

30-01-2026

Coya Therapeutics, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-030531), reporting multiple items: Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). This multi-item filing signals potentially significant developments, but no specific transaction details, financial metrics, dollar values, share counts, or impacts are disclosed in the provided information. No positive or negative quantitative metrics are available for balanced comparison.

30-01-2026

Amgen Inc filed an 8-K on January 30, 2026, disclosing under Item 1.02 the termination of a material definitive agreement. Item 9.01 provides financial statements and exhibits. No specific details on the agreement, parties, financial impacts, or quantitative metrics are disclosed.

30-01-2026

Enzon Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.03 material modifications to rights of security holders. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction values, or specific impacts are provided in the filing summary.

30-01-2026

ProMIS Neurosciences Inc. filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. While the material agreement may represent a strategic development, the unregistered equity sales could imply potential shareholder dilution. No specific transaction details, financial impacts, or quantitative metrics are disclosed.

30-01-2026

ALX Oncology Holdings Inc filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-030579), reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, transaction size, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

30-01-2026

Akebia Therapeutics, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on transaction terms, financial impacts, or personnel changes are provided.

30-01-2026

Edible Garden AG Inc filed a Form 8-K on January 30, 2026 (AccNo: 0001477932-26-000522), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing indicates governance and shareholder rights changes, but specific details on modifications, amendments, events, or exhibits are NOT_DISCLOSED. No quantitative financial impacts, positive or negative metrics, or directional biases are provided.

30-01-2026

Nuwellis, Inc. filed a multi-item Form 8-K on January 30, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures/elections/appointments of directors/officers and compensatory arrangements (Item 5.02), and Regulation FD disclosure (Item 7.01). No quantitative financial metrics, transaction values, share counts, or specific impacts are disclosed. The filing includes exhibits under Item 9.01.

30-01-2026

OptimumBank Holdings, Inc. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No specific details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling potentially significant corporate actions, but lacks quantitative data for assessment.

30-01-2026

International Endeavors Corp filed a Form 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement's nature, parties, terms, or financial impacts provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

30-01-2026

Sky Century Investment, Inc. filed an 8-K on January 30, 2026, reporting material modifications to rights of security holders under Item 3.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the nature of the modifications, events, or exhibits provided. No quantitative financial metrics, impacts, or comparisons are disclosed.

30-01-2026

SmartKem, Inc. filed an 8-K on 2026-01-30 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No quantitative details, transaction terms, financial impacts, or other metrics are provided in the filing summary. This represents a multi-item mandatory disclosure with limited specifics available.

30-01-2026

International Land Alliance Inc. filed a Form 8-K on January 30, 2026, reporting multiple material events under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 3.02 (Unregistered Sales of Equity Securities), with Item 9.01 listing Financial Statements and Exhibits. No quantitative details such as transaction values, share counts, or financial impacts are disclosed in the provided information. This multi-item filing signals potentially significant corporate actions but lacks specifics on positive or negative implications.

• ·Multi-item 8-K filing indicating mandatory disclosures for material agreement, financial obligation, and equity securities sales
• ·AccNo: 0001493152-26-004441, Size: 432 KB
• ·Sector: NOT_DISCLOSED

30-01-2026

Kelly Services Inc filed a multi-item Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031768), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.01 (Changes in Control of Registrant), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, named parties, quantitative metrics, or period-over-period comparisons are disclosed in the provided filing information.

30-01-2026

INVO Fertility, Inc. filed a multi-item Form 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, alongside other events (Item 8.01) and exhibits (Item 9.01). While the material agreement suggests potential strategic developments, the unregistered equity sales indicate possible shareholder dilution. No specific transaction details, financial metrics, or dollar values were disclosed.

30-01-2026

BranchOut Food Inc. filed a Form 8-K on January 30, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing covering a new agreement, financial results, and new financial obligations, but specific transaction details, dollar values, financial metrics, or performance comparisons are NOT_DISCLOSED. No positive or negative metrics, period-over-period changes, or guidance revisions are provided in the available information.

30-01-2026

Beeline Holdings, Inc. filed an 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative financial metrics, transaction values, or performance comparisons are provided in the filing summary.

30-01-2026

Yellowstone Midco Holdings II, LLC filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, named individuals, or specific details on the events were disclosed. This multi-item filing indicates significant governance and contractual changes without disclosed positive or negative impacts.

• ·Multi-item mandatory 8-K filing covering governance changes and a material agreement.
• ·No revenue, earnings, balance sheet effects, guidance, or dollar values disclosed.
• ·Critical missing information: Specific details of the material definitive agreement, identities of departing/appointed directors/officers, nature of rights modifications or amendments, any financial exhibits content, dollar value or size of transaction, period-over-period metrics. Analysis confidence: LOW (<50% key data available).

30-01-2026

Generation Income Properties, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, dollar impacts, or additional details such as reasons for delisting, balance sheet effects, or guidance changes are disclosed.

30-01-2026

Direct Digital Holdings, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

30-01-2026

TuHURA Biosciences, Inc./NV filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031742), under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, positive developments, or additional details such as reasons, impacts, or timelines were disclosed. This represents a material negative event with no offsetting positives mentioned.

• ·Filing size: 167 KB
• ·Sector: not specified

30-01-2026

Microvision, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001493152-26-004505), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, quantitative metrics, or other data explicitly stated. No positive, negative, or flat performance metrics are disclosed.

30-01-2026

NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP /DC/ filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, transaction size, parties, financial impacts, or metrics disclosed in the provided information. No positive or negative quantitative changes are mentioned.

30-01-2026

Marchex Inc filed an 8-K on 2026-01-30 disclosing Item 1.01 Entry into a Material Definitive Agreement alongside Item 5.02 regarding Departure of Directors or Certain Officers, Election of Directors, Appointment of Certain Officers, and Compensatory Arrangements of Certain Officers. This is a multi-item filing with no specific details on the agreement terms, personnel involved, or financial implications provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

30-01-2026

Velocity Financial, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 8.01 other events, with Item 9.01 listing financial statements and exhibits. No specific details on the agreement, events, dollar values, financial impacts, or performance metrics are disclosed in the provided filing summary. No positive or negative metrics, period-over-period comparisons, or quantitative data are mentioned.

30-01-2026

Zillow Group, Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No quantitative details such as transaction value, financial terms, or impact on revenue, earnings, or balance sheet were disclosed. This is a multi-item mandatory filing with no additional metrics, guidance changes, or scheduled events mentioned.

30-01-2026

Intuit Inc. filed an 8-K on January 30, 2026 (AccNo: 0000896878-26-000008, Size: 887 KB), disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, terms, strategic context, or financial metrics are disclosed in the provided filing summary.

30-01-2026

VYNE Therapeutics Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, parties, financial impacts, or quantitative metrics are provided in the filing summary.

30-01-2026

Laird Superfood, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details, dollar values, personnel names, or financial impacts are disclosed.

30-01-2026

Dragonfly Energy Holdings Corp. filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and attaching financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, parties, or financial impacts are disclosed. This is a multi-item filing focused on a material event with no quantitative metrics provided.

30-01-2026

Expion360 Inc. filed a Form 8-K on 2026-01-30 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, positive developments, dollar values, or reasons for the delisting were disclosed. This represents a material negative event with no offsetting positives mentioned.

• ·Accession Number: 0001903596-26-000022
• ·Filing size: 202 KB
• ·Sector: NOT_DISCLOSED

30-01-2026

GigCapital9 Corp. filed a Form 8-K on January 30, 2026, disclosing multiple events including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departures or appointments of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03), along with other events (Item 8.01) and exhibits (Item 9.01). No specific transaction details, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This multi-item filing signals potential strategic, governance, and capital structure changes, but lacks details to assess directionality.

30-01-2026

AB International Group Corp. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 provides financial statements and exhibits. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed.

30-01-2026

IMAC Holdings, Inc. filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or impacts provided. No positive or negative financial metrics, comparisons, or guidance changes are mentioned.

30-01-2026

Arrive AI Inc. filed an 8-K on January 30, 2026, reporting Item 1.01 Entry into a Material Definitive Agreement and Item 3.02 Unregistered Sales of Equity Securities, with Item 9.01 Financial Statements and Exhibits. No specific transaction details, dollar values, parties, strategic rationale, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

30-01-2026

NanoVibronix, Inc. filed a Form 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 3.03 material modifications to rights of security holders, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction values, financial impacts, or specific terms are disclosed in the provided filing summary.

30-01-2026

FUSE GROUP HOLDING INC. filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific transaction details, dollar values, strategic context, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

30-01-2026

PennantPark Investment Corp filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction values, or impacts are disclosed in the provided filing summary.

30-01-2026

Comstock Inc. filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, alongside Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No specific transaction details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This multi-item filing signals potentially strategic developments but also possible dilution from equity sales.

30-01-2026

Tenaya Therapeutics, Inc. filed an 8-K on 2026-01-30 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, which is a material negative event signaling potential loss of exchange listing and reduced liquidity. Item 5.02 discloses departures of directors or certain officers, elections, appointments, or compensatory arrangements, with unspecified direction that could indicate leadership changes but lacks positive or negative details. Item 9.01 includes financial statements and exhibits, providing additional context without specified metrics.

30-01-2026

Saratoga Investment Corp. filed a Form 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, terms, positive or negative impacts, or other metrics are provided in the filing summary.

30-01-2026

Aspire Biopharma Holdings, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004543), reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. This constitutes a multi-item mandatory disclosure with no quantitative details on transaction values, share counts, or financial impacts provided. No positive or negative metrics are disclosed.

30-01-2026

ASP Isotopes Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement. No specific details on the agreement's terms, parties, value, or financial impact are disclosed in the available filing summary. No quantitative metrics, comparisons, or other items are mentioned.

30-01-2026

Blink Charging Co. filed a Form 8-K on 2026-01-30 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. Item 9.01 covers financial statements and exhibits. No financial metrics, transaction values, or specific reasons for the delisting event were disclosed.

• ·Accession Number: 0001493152-26-004537
• ·Filing size: 205 KB
• ·Sector: not specified

30-01-2026

Aspira Women's Health Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 lists financial statements and exhibits. No specific transaction details, dollar values, financial metrics, or performance comparisons are disclosed.

30-01-2026

Madrigal Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details, financial terms, impacts, or quantitative metrics are disclosed in the provided filing summary.

30-01-2026

NN Inc filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. No specific details, dollar values, strategic context, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or performance comparisons available.

30-01-2026

DocGo Inc. filed an 8-K on January 30, 2026, under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No additional details on the specific reason, financial impacts, or strategic implications are disclosed. This event signals potential liquidity and visibility challenges for shareholders.

30-01-2026

Safe & Green Development Corp filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No positive financial metrics, growth indicators, or offsetting developments were disclosed. This event signals significant regulatory or compliance issues impacting stock market access.